Skip to main content
. 2021 Aug 23;90(4):627–639. doi: 10.1002/ana.26172

FIGURE 2.

FIGURE 2

Days from first ChAdOx1 dose administration to neurological symptoms onset for cerebral sinus and/or venous thrombosis (CVT) and non‐CVT events.